Highlights
NASDAQ: VKTX       Viking Thera
Last Price Today's Change   Day's Range   Trading Volume
13.83   -0.61 (4.22%)  13.75 - 14.83  2,450,700

Overview

 
Avg Volume (4 weeks):4,984,611
4 Weeks Range:13.25 - 20.85
4 Weeks Price Volatility (%):
7.63%
52 Weeks Range:2.08 - 24.00
52 Weeks Price Volatility (%):
53.60%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. Its second program is focused on the development of orally available small molecule thyroid hormone receptor beta agonists.

  Be the first to like this.
 


 

2759  4994  739  220 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SPY 276.25-0.15 
 AMD 23.66-2.96 
 GE 12.56+0.18 
 QQQ 173.02-0.16 
 EEM 39.67+0.37 
 XLF 26.67+0.10 
 VXX 34.05-0.60 
 BAC 28.32+0.07 
 F 8.50-0.01 
 TTNP 0.378+0.057 
Partners & Brokers